Access Program Information
To evaluate 68Ga-DOTATATE PET/CT for staging of patients with carcinoid, neuroendocrine
tumors, medullary thyroid cancer and other cancers expressing somatostatin receptors.
To evaluate 68Ga-DOTATATE PET/CT for staging of patients with carcinoid, neuroendocrine
tumors, medullary thyroid cancer and other cancers expressing somatostatin receptors.